Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Heart Test Laboratories Equity Warrant Exp 15th June 2027 HSCSW

HeartSciences Inc. is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. The Company has libraries of artificial intelligence-enhanced electrocardiography (AI-ECG) algorithms and is developing AI-ECG solutions to be made available on either a hardware- agnostic cloud-based platform or its... see more

Recent & Breaking News (NDAQ:HSCSW)

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results

GlobeNewswire December 16, 2024

HeartSciences' AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement

GlobeNewswire November 13, 2024

HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit

GlobeNewswire October 14, 2024

HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results

GlobeNewswire September 12, 2024

HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission

GlobeNewswire September 12, 2024

HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results

GlobeNewswire July 29, 2024

Innovation Value Institute Analysis Demonstrates HeartSciences' MyoVista® wavECG(TM) Potential to Improve Cardiovascular Pathway Efficiency

GlobeNewswire July 26, 2024

HeartSciences Selected to Demonstrate MyoVista® wavECG(TM) at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare

GlobeNewswire July 25, 2024

HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction

GlobeNewswire July 11, 2024

HeartSciences Regains Compliance with Nasdaq Listing Requirements

GlobeNewswire June 4, 2024

HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio

GlobeNewswire May 20, 2024

HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG

GlobeNewswire April 24, 2024

HeartSciences to Present at the LD Micro Invitational XIV Conference

GlobeNewswire April 2, 2024

HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients

GlobeNewswire March 26, 2024

HeartSciences Reports Third Quarter Fiscal 2024 Financial Results

GlobeNewswire March 14, 2024

HeartSciences' Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes

GlobeNewswire March 12, 2024

HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology

GlobeNewswire March 6, 2024

HeartSciences Adds Key Advisor to its Scientific Advisory Board

GlobeNewswire February 26, 2024

HeartSciences Expands its Scientific Advisory Board

GlobeNewswire February 12, 2024

HeartSciences Appoints New Scientific Advisory Board Member

GlobeNewswire February 1, 2024